Rubius Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2017 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Rubius Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2017 to Q4 2022.
  • Rubius Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending December 31, 2022 was 300M shares, a 100% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 300M +150M +100% Dec 31, 2022 10-K 2023-02-27
Q3 2022 300M +150M +100% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 150M 0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 150M 0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 150M 0 0% Dec 31, 2021 10-K 2023-02-27
Q3 2021 150M 0 0% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 150M 0 0% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 150M 0 0% Mar 31, 2021 10-Q/A 2021-08-20
Q4 2020 150M 0 0% Dec 31, 2020 10-K 2022-02-25
Q3 2020 150M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 150M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 150M 0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 150M 0 0% Dec 31, 2019 10-K 2021-02-23
Q3 2019 150M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 150M +71M +89.9% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 150M +75M +100% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 150M +85M +131% Dec 31, 2018 10-K 2020-03-12
Q3 2018 150M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 79M Jun 30, 2018 10-K 2021-02-23
Q1 2018 75M Mar 31, 2018 10-K 2021-02-23
Q4 2017 65M Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.